Marcin Krawczyk

7.4k total citations
203 papers, 3.3k citations indexed

About

Marcin Krawczyk is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Marcin Krawczyk has authored 203 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Epidemiology, 77 papers in Surgery and 73 papers in Hepatology. Recurrent topics in Marcin Krawczyk's work include Liver Disease Diagnosis and Treatment (96 papers), Liver Diseases and Immunity (39 papers) and Liver Disease and Transplantation (39 papers). Marcin Krawczyk is often cited by papers focused on Liver Disease Diagnosis and Treatment (96 papers), Liver Diseases and Immunity (39 papers) and Liver Disease and Transplantation (39 papers). Marcin Krawczyk collaborates with scholars based in Germany, Poland and Italy. Marcin Krawczyk's co-authors include Frank Lammert, Piero Portincasa, F Grünhage, Piotr Milkiewicz, Leonilde Bonfrate, Caroline S. Stokes, Agostino Di Ciaula, Vincent Zimmer, Roman Liebe and Joanna Raszeja‐Wyszomirska and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Marcin Krawczyk

183 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcin Krawczyk Germany 33 1.8k 1.1k 898 603 520 203 3.3k
Anna Licata Italy 35 2.0k 1.1× 743 0.7× 1.6k 1.8× 348 0.6× 288 0.6× 159 4.1k
Jean P. Molleston United States 37 2.0k 1.1× 1.9k 1.8× 1.3k 1.5× 681 1.1× 581 1.1× 146 4.5k
Byoung Kuk Jang South Korea 28 1.1k 0.6× 688 0.7× 806 0.9× 251 0.4× 534 1.0× 134 2.8k
Teru Kumagi Japan 31 1.6k 0.9× 920 0.9× 1.2k 1.4× 449 0.7× 296 0.6× 181 3.2k
Christian Datz Austria 43 3.1k 1.7× 597 0.6× 2.0k 2.2× 822 1.4× 335 0.6× 176 6.3k
Mark Muthiah Singapore 32 2.5k 1.4× 636 0.6× 1.2k 1.4× 1.0k 1.7× 167 0.3× 184 4.1k
Woo Kyu Jeon South Korea 39 1.4k 0.8× 1.7k 1.6× 696 0.8× 464 0.8× 1.2k 2.3× 122 4.5k
Piotr Milkiewicz Poland 35 1.8k 1.0× 1.5k 1.4× 1.9k 2.1× 199 0.3× 505 1.0× 210 3.9k
Philippe Sogni France 30 1.8k 1.0× 710 0.7× 1.9k 2.1× 222 0.4× 264 0.5× 164 3.2k
Takaomi Kessoku Japan 28 1.9k 1.1× 618 0.6× 935 1.0× 769 1.3× 138 0.3× 126 3.1k

Countries citing papers authored by Marcin Krawczyk

Since Specialization
Citations

This map shows the geographic impact of Marcin Krawczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Krawczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Krawczyk more than expected).

Fields of papers citing papers by Marcin Krawczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcin Krawczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Krawczyk. The network helps show where Marcin Krawczyk may publish in the future.

Co-authorship network of co-authors of Marcin Krawczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Marcin Krawczyk. A scholar is included among the top collaborators of Marcin Krawczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcin Krawczyk. Marcin Krawczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Best, Jan, Julia Kälsch, Marcin Krawczyk, et al.. (2025). Metabolische Dysfunktion-assoziierte steatotische Lebererkrankung und hepatozelluläres Karzinom. 20(2). 123–133.
2.
Kruk, Beata, Joanna Raszeja‐Wyszomirska, Marcin Krawczyk, & Piotr Milkiewicz. (2025). Fatigue and itch severity in patients with PBC and PSC: Prospective analysis of two large cohorts. European Journal of Clinical Investigation. 55(7). e70041–e70041. 1 indexed citations
3.
4.
5.
Adrych, Krystian, et al.. (2024). Artificial replication cohort: Leveraging AI‐fabricated data for genetic studies. Liver International. 44(6). 1286–1289. 1 indexed citations
6.
Żorniak, Michał, Paweł Madej, Susanne N. Weber, et al.. (2023). Liver phenotypes in PCOS: Analysis of exogenous and inherited risk factors for liver injury in two European cohorts. Liver International. 43(5). 1080–1088. 4 indexed citations
7.
Böhm, Michael, Javed Butler, Marcin Krawczyk, et al.. (2023). Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial. European Journal of Heart Failure. 25(8). 1375–1383. 12 indexed citations
8.
Casper, Markus, Marcin Krawczyk, & Frank Lammert. (2023). Endoscopic Mucosal Resection of Non-pedunculated Colorectal Polyps ≥20mm: Outcome in a Self-taught Skills Environment. Journal of Gastrointestinal and Liver Diseases. 32(2). 150–155.
9.
Kirchmeyer, Mélanie, Anthoula Gaigneaux, Anita Arslanow, et al.. (2023). Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3 I148M risk allele. Hepatology Communications. 7(12). 7 indexed citations
10.
Hendrikx, Tim, Florentina Porsch, Máté G. Kiss, et al.. (2022). Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH. Journal of Hepatology. 77(5). 1373–1385. 125 indexed citations
11.
Schmartz, Georges P, Nicole Ludwig, Matthias Hannig, et al.. (2022). Systematic Cross-Biospecimen Evaluation of DNA Extraction Kits for Long- and Short-Read Multi-Metagenomic Sequencing Studies. Genomics Proteomics & Bioinformatics. 20(2). 405–417. 9 indexed citations
12.
Casper, Markus, et al.. (2022). Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: the care must go on. European journal of medical research. 27(1). 41–41. 1 indexed citations
13.
Kaddu‐Mulindwa, Dominic, et al.. (2022). Liver stiffness as surrogate parameter in emergency assessment for inpatient health care utilization. PLoS ONE. 17(4). e0266069–e0266069. 1 indexed citations
14.
Lang, Sonja, Anna Martin, Xinlian Zhang, et al.. (2021). Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease. Liver International. 41(7). 1576–1591. 22 indexed citations
15.
Arslanow, Anita, Caroline S. Stokes, Susanne N. Weber, et al.. (2015). The common PNPLA 3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter ( CAP ). Liver International. 36(3). 418–426. 18 indexed citations
16.
Krawczyk, Marcin, Michał Wasilewicz, Marek Hartleb, et al.. (2015). Rozpoznawanie i leczenie raka wątrobowokomórkowego — rekomendacje Sekcji Hepatologicznej Polskiego Towarzystwa Gastroenterologii. 7(3). 65–89. 1 indexed citations
17.
Krawczyk, Marcin. (2011). Oczekiwany poziom stopy procentowej a popyt na pieniądz. Ekonomista. 777–794. 1 indexed citations
18.
Krawczyk, Marcin, et al.. (2011). Zespół metaboliczny. Cz.1. Rys historyczny i patomechanizmy. Żywienie Człowieka i Metabolizm. 38(5).
19.
Ołdakowska‐Jedynak, Urszula, Jadwiga Dwilewicz‐Trojaczek, Mariusz Tomaniak, et al.. (2011). 559 THE OUTCOME OF LIVER TRANSPLANTATION FOR BUDD-CHIARI SYNDROME – A SINGLE CENTER EXPERIENCE. Journal of Hepatology. 54. S228–S228. 1 indexed citations
20.
Ostrowski, K, et al.. (2001). New therapeutic options of carcinoid syndrome metastatic to the liver.. PubMed. 7 Suppl 1. 321–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Licata Breakdown of academic impact, for papers by Jean P. Molleston Breakdown of academic impact, for papers by Byoung Kuk Jang Breakdown of academic impact, for papers by Teru Kumagi Breakdown of academic impact, for papers by Christian Datz Breakdown of academic impact, for papers by Mark Muthiah Breakdown of academic impact, for papers by Woo Kyu Jeon Breakdown of academic impact, for papers by Piotr Milkiewicz Breakdown of academic impact, for papers by Philippe Sogni Breakdown of academic impact, for papers by Takaomi Kessoku
Rankless by CCL
2026